212 related articles for article (PubMed ID: 8958272)
21. Lamivudine treatment of decompensated hepatitis B virus-related cirrhosis.
Zhang FK
Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):10-5. PubMed ID: 16481275
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis viruses and liver transplantation.
Samuel D; Feray C; Bismuth H
J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S335-41. PubMed ID: 9407355
[TBL] [Abstract][Full Text] [Related]
23. Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis.
Joya-Vazquez PP; Dodson FS; Dvorchik I; Gray E; Chesky A; Demetris AJ; Shakil O; Fung JJ; Vargas HE
Transplantation; 2002 May; 73(10):1598-602. PubMed ID: 12042646
[TBL] [Abstract][Full Text] [Related]
24. Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort.
Yao FY; Terrault NA; Freise C; Maslow L; Bass NM
Hepatology; 2001 Aug; 34(2):411-6. PubMed ID: 11481627
[TBL] [Abstract][Full Text] [Related]
25. Study on the efficacy and safety of adefovir dipivoxil treatment in post-liver transplant patients with hepatitis B virus infection and lamivudine-resistant hepatitis B virus.
Bárcena R; Del Campo S; Moraleda G; Casanovas T; Prieto M; Buti M; Moreno JM; Cuervas V; Fraga E; De la Mata M; Otero A; Delgado M; Loinaz C; Barrios C; Dieguez ML; Mas A; Sousa JM; Herrero JI; Muñoz R; Avilés JF; Gonzalez A; Rueda M
Transplant Proc; 2005 Nov; 37(9):3960-2. PubMed ID: 16386596
[TBL] [Abstract][Full Text] [Related]
26. Extension of transplantation free time by lamivudine in patients with hepatitis B-induced decompensated cirrhosis.
Kitay-Cohen Y; Ben-Ari Z; Tur-Kaspa R; Fainguelernt H; Lishner M
Transplantation; 2000 Jun; 69(11):2382-3. PubMed ID: 10868644
[TBL] [Abstract][Full Text] [Related]
27. High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation.
Mutimer D; Pillay D; Dragon E; Tang H; Ahmed M; O'Donnell K; Shaw J; Burroughs N; Rand D; Cane P; Martin B; Buchan S; Boxall E; Barmat S; Gutekunst K; McMaster P; Elias E
J Hepatol; 1999 Apr; 30(4):715-21. PubMed ID: 10207815
[TBL] [Abstract][Full Text] [Related]
28. An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.
Han SH; Ofman J; Holt C; King K; Kunder G; Chen P; Dawson S; Goldstein L; Yersiz H; Farmer DG; Ghobrial RM; Busuttil RW; Martin P
Liver Transpl; 2000 Nov; 6(6):741-8. PubMed ID: 11084061
[TBL] [Abstract][Full Text] [Related]
29. Fibrosing cholestatic hepatitis secondary to precore/core promoter hepatitis B variant with lamivudine resistance: successful retransplantation with combination adefovir dipivoxil and hepatitis B immunoglobulin.
Lo CM; Cheung ST; Ng IO; Liu CL; Lai CL; Fan ST
Liver Transpl; 2004 Apr; 10(4):557-63. PubMed ID: 15048802
[TBL] [Abstract][Full Text] [Related]
30. Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.
Franchello A; Ghisetti V; Marzano A; Romagnoli R; Salizzoni M
Liver Transpl; 2005 Aug; 11(8):922-8. PubMed ID: 16035057
[TBL] [Abstract][Full Text] [Related]
31. Clinical improvement in patients with decompensated liver disease caused by hepatitis B after treatment with lamivudine.
Sponseller CA; Bacon BR; Di Bisceglie AM
Liver Transpl; 2000 Nov; 6(6):715-20. PubMed ID: 11084057
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation.
Bartholomew MM; Jansen RW; Jeffers LJ; Reddy KR; Johnson LC; Bunzendahl H; Condreay LD; Tzakis AG; Schiff ER; Brown NA
Lancet; 1997 Jan; 349(9044):20-2. PubMed ID: 8988118
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of lamivudine therapy for advanced liver disease in patients with precore mutant hepatitis B virus infection awaiting liver transplantation.
Andreone P; Biselli M; Gramenzi A; Cursaro C; Morelli MC; Sama C; Lorenzini S; Spinucci G; Porzio F; Felline F; Di Giammarino L; Bernardi M
Transplantation; 2002 Oct; 74(8):1119-24. PubMed ID: 12438957
[TBL] [Abstract][Full Text] [Related]
34. Lamivudine monoprophylaxis for de novo HBV infection in HBsAg-negative recipients with HBcAb-positive liver grafts.
Vizzini G; Gruttadauria S; Volpes R; D'Antoni A; Pietrosi G; Filì D; Petridis I; Pagano D; Tuzzolino F; Santonocito MM; Gridelli B
Clin Transplant; 2011; 25(1):E77-81. PubMed ID: 21039887
[TBL] [Abstract][Full Text] [Related]
35. Prevention of hepatitis B recurrence after liver transplantation using lamivudine and hepatitis B immune globulin.
Ołdakowska-Jedynak U; Paczek L; Foroncewicz B; Mucha K; Nyckowski P; Zieniewicz K; Ziarkiewicz-Wróblewska B; Ziółkowski J; Pilecki T; Patkowski W; Górnicka B; Paczkowska A; Krawczyk M
Ann Transplant; 2007; 12(3):28-32. PubMed ID: 18290567
[TBL] [Abstract][Full Text] [Related]
36. End-stage liver disease and liver transplantation: role of lamivudine therapy in patients with chronic hepatitis B.
Keeffe EB
J Med Virol; 2000 Jul; 61(3):403-8. PubMed ID: 10861654
[TBL] [Abstract][Full Text] [Related]
37. [Lamivudine as prophylaxis against hepatitis B virus reinfection following orthotopic liver transplantation].
Zheng S; Wu J; Wang W; Huang D; Liang T; Lu A
Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(7):445-8. PubMed ID: 12133511
[TBL] [Abstract][Full Text] [Related]
38. Twenty-four year single-center experience of hepatitis B virus infection in heart transplantation.
Chen YC; Chuang MK; Chou NK; Chi NH; Wu IH; Chen YS; Yu HY; Huang SC; Wang CH; Tsao CI; Ko WJ; Wang SS
Transplant Proc; 2012 May; 44(4):910-2. PubMed ID: 22564582
[TBL] [Abstract][Full Text] [Related]
39. Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization.
Sawyer RG; McGory RW; Gaffey MJ; McCullough CC; Shephard BL; Houlgrave CW; Ryan TS; Kuhns M; McNamara A; Caldwell SH; Abdulkareem A; Pruett TL
Ann Surg; 1998 Jun; 227(6):841-50. PubMed ID: 9637547
[TBL] [Abstract][Full Text] [Related]
40. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation].
Liu J; Wu GC; Zhang ZT; Wu P; Zhang D; Sun MC; Gao DC; Wang Y; Jia JD; Wang BE
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):976-9. PubMed ID: 16194352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
